1. Home
  2. NNBR vs BMEA Comparison

NNBR vs BMEA Comparison

Compare NNBR & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNBR
  • BMEA
  • Stock Information
  • Founded
  • NNBR 1980
  • BMEA 2017
  • Country
  • NNBR United States
  • BMEA United States
  • Employees
  • NNBR N/A
  • BMEA N/A
  • Industry
  • NNBR Industrial Machinery/Components
  • BMEA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNBR Industrials
  • BMEA Health Care
  • Exchange
  • NNBR Nasdaq
  • BMEA Nasdaq
  • Market Cap
  • NNBR 173.8M
  • BMEA 145.0M
  • IPO Year
  • NNBR 1994
  • BMEA 2021
  • Fundamental
  • Price
  • NNBR $2.89
  • BMEA $3.46
  • Analyst Decision
  • NNBR
  • BMEA Buy
  • Analyst Count
  • NNBR 0
  • BMEA 13
  • Target Price
  • NNBR N/A
  • BMEA $27.92
  • AVG Volume (30 Days)
  • NNBR 228.9K
  • BMEA 414.8K
  • Earning Date
  • NNBR 03-10-2025
  • BMEA 03-31-2025
  • Dividend Yield
  • NNBR N/A
  • BMEA N/A
  • EPS Growth
  • NNBR N/A
  • BMEA N/A
  • EPS
  • NNBR N/A
  • BMEA N/A
  • Revenue
  • NNBR $470,310,000.00
  • BMEA N/A
  • Revenue This Year
  • NNBR N/A
  • BMEA N/A
  • Revenue Next Year
  • NNBR $0.69
  • BMEA N/A
  • P/E Ratio
  • NNBR N/A
  • BMEA N/A
  • Revenue Growth
  • NNBR N/A
  • BMEA N/A
  • 52 Week Low
  • NNBR $2.38
  • BMEA $3.25
  • 52 Week High
  • NNBR $5.20
  • BMEA $19.36
  • Technical
  • Relative Strength Index (RSI)
  • NNBR 41.16
  • BMEA 34.96
  • Support Level
  • NNBR $3.12
  • BMEA $3.25
  • Resistance Level
  • NNBR $3.52
  • BMEA $3.75
  • Average True Range (ATR)
  • NNBR 0.20
  • BMEA 0.24
  • MACD
  • NNBR -0.01
  • BMEA 0.00
  • Stochastic Oscillator
  • NNBR 1.56
  • BMEA 21.43

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Share on Social Networks: